RNWL
INTERNATIONAL REGISTRATION RENEWED
02/10/2025
Voltar para busca
Dado oficial do USPTO
CONTERA PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
03/10/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
04/09/2015
Data de registro
03/01/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
14/07/2023
Última transação
03/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
24
Localização do titular
DK
Examinador
WEIGLE,KATHERINE CONNOLLY
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "CONTERA PHARMA" with straight vertical lines appearing below the wording, all in blue.
Titulares e representantes
Titulares
Contera Pharma A/S
C. A. (pessoa física)
Representantes
Julie A. Greenberg Fishman Stewart PLLC
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Antibiotics; antiviralschemical preparations for pharmaceutical purposesfor treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; drugs for medical purposespharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; medicines for human purposes for treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; pharmaceutical preparations for the treatmentprevention or alleviation of diseases of the central nervous systemneurological disorderspsychiatric disordersmovement disordersextrapyramidal disordershyperkinetic movement disordershypokinetic movement disordersparkinsonismParkinson's Diseasedyskinesias and complications arising from same; vitamin preparations; health supplements for medical usehealth food supplementsdietary and nutritional supplementsherbal supplements
Classe 35
Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; market search; market study; advertising services; arranging of pharmaceutical saleprocuring of contracts for the purchase and sale of pharmaceuticals; export-import agency; sales agency business of health supplementary foodmarketing services for health supplementary foodspromotional marketing and representation services for sales to the public sector of health supplementary foodindependent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/09/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
14/03/2024
C71T
CANCELLED SECTION 71
14/07/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/01/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/07/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/07/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/01/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/09/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
31/08/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
22/04/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2017
FIMP
FINAL DISPOSITION PROCESSED
05/04/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/04/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/03/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/12/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/11/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/10/2016
PUBO
PUBLISHED FOR OPPOSITION
18/10/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
28/09/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
28/09/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/09/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/09/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/08/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/08/2016
ALIE
ASSIGNED TO LIE
14/08/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2016
RFNT
REFUSAL PROCESSED BY IB
27/02/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/02/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2016
RFRR
REFUSAL PROCESSED BY MPU
08/02/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/02/2016
CNRT
NON-FINAL ACTION WRITTEN
04/02/2016
DOCK
ASSIGNED TO EXAMINER
03/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
30/01/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CONTERA PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.